Stock Analysis on Net

Pfizer Inc. (NYSE:PFE)

$24.99

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Pfizer Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in millions

Microsoft Excel
Sep 28, 2025 Jun 29, 2025 Mar 30, 2025 Dec 31, 2024 Sep 29, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Oct 1, 2023 Jul 2, 2023 Apr 2, 2023 Dec 31, 2022 Oct 2, 2022 Jul 3, 2022 Apr 3, 2022 Dec 31, 2021 Oct 3, 2021 Jul 4, 2021 Apr 4, 2021 Dec 31, 2020 Sep 27, 2020 Jun 28, 2020 Mar 29, 2020
Short-term borrowings, including current portion of long-term debt
Trade accounts payable
Dividends payable
Income taxes payable
Accrued compensation and related items
Deferred revenues
Other current liabilities
Current liabilities
Long-term debt, excluding current portion
Pension and postretirement benefit obligations
Noncurrent deferred tax liabilities
Other taxes payable
Other noncurrent liabilities
Noncurrent liabilities
Total liabilities
Preferred stock
Common stock
Additional paid-in capital
Treasury stock
Retained earnings
Accumulated other comprehensive loss
Total Pfizer Inc. shareholders’ equity
Equity attributable to noncontrolling interests
Total equity
Total liabilities and equity

Based on: 10-Q (reporting date: 2025-09-28), 10-Q (reporting date: 2025-06-29), 10-Q (reporting date: 2025-03-30), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-29), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-10-01), 10-Q (reporting date: 2023-07-02), 10-Q (reporting date: 2023-04-02), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-10-02), 10-Q (reporting date: 2022-07-03), 10-Q (reporting date: 2022-04-03), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-10-03), 10-Q (reporting date: 2021-07-04), 10-Q (reporting date: 2021-04-04), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-27), 10-Q (reporting date: 2020-06-28), 10-Q (reporting date: 2020-03-29).


Short-term borrowings
The short-term borrowings showed significant volatility over the periods. Notably, there was a sharp decline from 16,007 million USD at the beginning of 2020 to 2,703 million USD by the end of the same year, followed by intermittent increases and decreases. The highest recorded value after 2020 was 10,350 million USD in the first quarter of 2024, indicating fluctuating short-term financing needs.
Trade accounts payable
Trade payables generally increased over time with some fluctuations. Starting from 3,972 million USD in early 2020, the value peaked around 6,809 million USD in late 2022 before slightly decreasing and stabilizing around 5,000 to 5,600 million USD in the latest quarters.
Dividends payable
Dividends payable had intermittent data but generally showed a gradual increase from approximately 2,111 million USD in mid-2020 to 2,445 million USD by mid-2025, suggesting consistent dividend obligations.
Income taxes payable
Income taxes payable fluctuated considerably, peaking at 4,496 million USD in the third quarter of 2021 and generally oscillating around 2,000 to 3,500 million USD in other periods. The trend reflects changes in taxable income and tax accruals.
Accrued compensation and related items
There were noticeable fluctuations in accrued compensation, with values ranging from about 1,972 million USD up to 3,838 million USD, peaking mostly in late 2024 and early 2025. This may reflect payroll timing differences or varying employee-related liabilities.
Deferred revenues
Data for deferred revenues starts from late 2020 and shows a rise to a peak of 6,191 million USD in late 2022, followed by a sharp decline to around 900 million USD by mid-2025, indicating changes in service or product prepayments revenue recognition.
Other current liabilities
Other current liabilities increased significantly from approximately 10,515 million USD in early 2020 to a peak of nearly 24,938 million USD in late 2021, before experiencing gradual fluctuations and ending near 19,510 million USD by mid-2025. This suggests growth in miscellaneous short-term obligations.
Current liabilities
Overall current liabilities showed substantial variation, spiking in late 2021 near 47,794 million USD, then fluctuating but trending downward toward approximately 36,596 million USD by mid-2025.
Long-term debt
Long-term debt, excluding current portions, showed a notable increase during 2021 from about 31,704 million USD to over 61,356 million USD, remaining relatively stable around this higher level through 2024 and 2025, indicating increased long-term borrowing during that period.
Pension and postretirement benefit obligations
These obligations steadily declined from roughly 6,535 million USD in early 2020 to around 2,100 million USD by mid-2025, indicating a decrease in pension liabilities or improved funding status.
Noncurrent deferred tax liabilities
Noncurrent deferred tax liabilities showed variability, starting near 5,268 million USD in early 2020, dropping sharply in 2021 to several hundred million USD, then increasing again toward approximately 2,467 million USD by mid-2025, reflecting changes in deferred tax accounting.
Other taxes payable
Other taxes payable declined steadily from around 12,212 million USD in early 2020 to approximately 3,400 million USD by mid-2025, showing reduced tax-related liabilities in this category.
Other noncurrent liabilities
These liabilities increased gradually from about 6,812 million USD in 2020 to a peak near 16,540 million USD in late 2023, followed by minor decreasing fluctuations near 13,600 million USD by mid-2025, indicating rising and then slightly moderated long-term obligations.
Noncurrent liabilities
Noncurrent liabilities rose from 67,108 million USD in early 2020 to peak near 89,419 million USD in late 2023, before a slight decline to around 79,039 million USD by mid-2025, driven largely by changes in long-term debt and other noncurrent obligations.
Total liabilities
Total liabilities exhibited an increasing trend from about 101,000 million USD in early 2020 to a peak above 137,000 million USD in late 2023, then declining to approximately 115,635 million USD by mid-2025, reflecting borrowing and liability management fluctuations.
Shareholders' equity items
Common stock and additional paid-in capital showed gradual increases over time, with common stock increasing from roughly 470 million USD to 481 million USD and additional paid-in capital rising from about 87,000 million USD to over 94,000 million USD. Treasury stock consistently reflected a substantial negative value near -115,000 million USD, indicating share repurchases or treasury holdings.
Retained earnings
Retained earnings generally increased from 101,000 million USD early in 2020 to a peak of 131,101 million USD in early 2023, followed by some declines, ending near 121,149 million USD by mid-2025, reflecting cumulative earnings less dividends.
Accumulated other comprehensive loss
This loss narrowed significantly from approximately -13,131 million USD in early 2020 to around -4,664 million USD in early 2021 but then lengthened again to near -8,000 million USD by mid-2025. The pattern indicates fluctuations in unrealized losses related to other comprehensive income elements.
Total shareholders’ equity
Equity rose from about 65,026 million USD in early 2020 to a peak just over 100,970 million USD in early 2023, then declined noticeably to about 90,000 million USD by mid-2025, illustrating variations in retained earnings and other equity components.
Total liabilities and equity
The total financial position expanded from around 166,336 million USD in early 2020 to peak near 226,501 million USD in mid-2023 before contracting slightly toward 208,731 million USD by mid-2025, reflecting overall growth followed by moderate reduction in combined liabilities and equity.